Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for prevention of hypocalcemia after thyroidectomy
ISRCTN74486450Phase 2Completed
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in hypocalcemia and hypoparathyroidism comparing Teriparatide with Standard clinical care / observation (2 arms). Primary endpoints: Serum calcium and Signs and symptoms of hypocalcemia. Started Feb 2016; status: completed.
02
Drugs
teriparatide
03
Conditions
hypocalcemiahypoparathyroidism
Beyond the preview
Go deeper on ISRCTN74486450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN74486450.